Overfield series · Part 3 of 3 · 4 November 2026
Who Can Say No? Physician Employment, Defense Funding and the Right to Replace an MSO
Professional independence turns on who holds the decisive rights when a physician and a management organization disagree. Employment decisions, legal-defense arrangements and exit rights are relevant lines of inquiry — but none is proof of unlawful control by itself
A professional corporation may keep its own name while buying most of its administration from another company. That can be lawful. The harder question is who can approve a protected decision, who can reverse it, who can replace the decision-maker, and what happens when the professional corporation wants a different manager. Two Overfield orders — one about a physician’s termination, one about who paid for his lawyer — make that discipline essential, because one of them contains strong evidence against the narrative an investigator might expect.
1. The termination record contains counterevidence
Court’s account On 11 August 2026 the court addressed plaintiffs’ request to continue the Rule 30(b)(6) deposition of Heather Hole about the August 2025 termination of Dr. Ross Chapman. Defense counsel had instructed Hole not to answer who terminated Chapman, why, and related attendance questions, invoking Chapman’s privacy rights under the California Constitution. Plaintiffs argued the information supported their theory that CFMG procured and retained clinicians in a way that kept costs low at the expense of care. The court found that theory “undermined” by Chapman’s own sworn testimony that his termination “was unrelated to treatment decisions regarding any CFMG patient,” and noted that plaintiffs cited no contrary evidence.V03
Court disposition The court ordered a further deposition of Chapman, refused further questioning of Hole on the same subject as cumulative, and made that refusal without prejudice to renewal after Chapman testifies again — noting that he might waive privacy or provide information that “casts doubt” on his earlier account.V03
Analysis That result must travel with any discussion of the termination. It is not responsible to write a treatment-retaliation narrative while omitting the evidence the court found undermined it. A different question remains open to properly supported inquiry: what authority the relevant organizations and individuals possessed. The reason for one termination and the allocation of corporate power are not the same question — but the existence of the second does not neutralise the adverse evidence on the first.
Legal rule The Medical Board’s guidance places “selection, hiring/firing (as it relates to clinical competency or proficiency)” of physicians among decisions a licensed physician must make. That qualifier matters. The guidance does not declare that every attendance, payroll or administrative step a manager performs is prohibited; a particular action has to be examined in context.V16
2. An organizational witness is not an owner
Legal rule Rule 30(b)(6) lets an organization designate “officers, directors, or managing agents, or designate other persons who consent to testify on its behalf,” and requires the designee to testify about information “known or reasonably available to the organization.”V07
Court’s account The orders identify both Hole and Blair Lukasik as CFMG’s Rule 30(b)(6) witnesses; ECF 87 describes Hole as a “CFMG employee,” and the joint statement describes Lukasik as CFMG’s designee on its financial condition from 2021 forward.V03V01V09
Analysis Under the rule, a designee’s employer is not decisive either way: a witness from outside the professional corporation would not make the designation improper or prove that a manager owns the practice, and a witness inside it would not prove independence. The informative questions are substantive — where the records are kept, who holds institutional knowledge, who prepares policy, who communicates decisions, and who has the final word. Any claim about a particular witness’s actual employer or authority should be tied to inspected testimony or employment records, not inferred from a brand name or a condensed judicial description. This publication has not read either deposition.
3. Two orders, two employer descriptions
Court’s account The February 2026 withdrawal order states that counsel “was originally retained by Wellpath, Defendant’s employer.” The August 2026 discovery order describes “the termination of defendant Ross Chapman’s employment with CFMG in August 2025.”V04V03
Analysis Neither order adjudicates who employed Chapman; each sentence appears in service of a different procedural question. The investigation records both descriptions in its court-record ledger rather than choosing one; the broader pattern of entity naming is tracked in the Relationship-Language Atlas. The divergence is itself a data point about how the two entities are described in a single court file — not a finding about either one.
4. Defense funding is a separate dependency
Court’s account The withdrawal order records that Wellpath retained Chapman’s counsel; that after the bankruptcy Wellpath terminated its defense and indemnification of him; that he was notified of his options; and that he neither retained counsel himself nor authorised continued representation, and stopped communicating. The court found withdrawal proper under California Rule of Professional Conduct 1.16(b)(4) and saw low risk of prejudice.V04
Analysis The legitimate inference is limited but real: arranging and paying for a physician’s defense are identifiable institutional functions that can shape a physician’s practical position. The order does not show that funding was conditioned on any clinical choice, that its termination punished testimony, or that counsel breached any duty. A coverage-based explanation tied to the bankruptcy is consistent with the order and is not refuted by it.
Four identities should be kept separate in any review: the physician-client; the person or organization that retained counsel; the payer; and the entity that owes any contractual defense or indemnity obligation. They may coincide, but that must be shown, not assumed.
Legal rule California’s attorney-conduct rules draw the same lines. Rule 1.8.6 conditions a lawyer’s acceptance of payment from someone other than the client on non-interference with the lawyer’s independent judgment, protection of client confidences and, with stated exceptions, the client’s informed written consent. Rule 5.4(c) forbids a lawyer to let a person who pays the lawyer to serve another direct or regulate the lawyer’s professional judgment. Those rules explain why payment does not itself establish control of the representation; they are not findings of any breach in Overfield.V23
The constructive policy question is whether professional-practice governance adequately separates clinical judgment from discretionary institutional support. Answering it requires the actual indemnity terms, coverage arrangements and decision process — not a presumption that every funding termination is retaliatory.
5. The strongest structural question: who can replace whom
Official position The California Attorney General filed an amicus brief “in support of neither party” on 30 March 2026 in Art Center Holdings, Inc. v. WCE CA Art, LLC (B338625, Second District, Division Three), and announced it on 1 April. The brief argues that when an agreement gives an unlicensed corporation the right to replace a medical practice’s physician-owner with a physician of its choice, “the corporation effectively owns and controls all aspects of the practice”; that such provisions travel under names like “continuity agreements,” “assignable options” or “stock transfer agreements”; that control need not be exercised to offend the corporate-practice bar; and that the trial court in that case correctly held such an arrangement unlawful.V19V20
Analysis The brief is an official litigation position, not appellate precedent, and this publication located no Court of Appeal decision in B338625 as of 4 November 2026. It is not evidence that CFMG’s instruments contain any such provision. Its relevance is to sharpen the right question. A right-to-leave inquiry must look at both directions of the relationship: can the professional corporation replace its management vendor, and who decides; can the manager select or replace the physician-owner, restrict share transfers, control essential assets or impose termination consequences; what financial obligations survive exit; and can records, systems and essential services move without surrendering protected professional authority?
Ordinary commercial friction is not proof of unlawful captivity. A valid debt, a reasonable transition period or protection for proprietary software can each have legitimate explanations. The question is whether the combination of terms transfers prohibited control — not whether changing vendors is cheap or convenient. These are document questions, and in litigation they have proved hard to reach. In Overfield, CFMG says it produced the management agreement under confidentiality; and, according to the defense’s description in ECF 95, a federal court in the Northern District declined on 21 April 2026 to compel CFMG–Wellpath management agreements or testimony about them in Smith.V09 Private damages cases are not designed to audit governance, which is one more reason the professional-control question belongs with the bodies that can lawfully demand the instruments. The public Overfield record does not supply a current CFMG share-transfer agreement, and it does not establish the use or availability of a replacement manager. The investigation’s existing analysis of those documents is in 18. Physician Ownership and the Missing Stock-Transfer Agreements and 19. The Right to Leave.
6. A 2026 law adds specificity, not a shortcut
Legal rule Health and Safety Code § 1191, operative 1 January 2026, bars a private equity group or hedge fund involved with a California physician practice from controlling or being delegated listed functions — including hiring and firing based on clinical competency — and voids contract terms that would allow it. It also bars certain non-compete and non-disparagement clauses in management contracts with such groups. Section 1190 defines “private equity group” and “hedge fund” and excludes, among others, passive contributors, hospital systems and public agencies.V22V21
Analysis Before applying § 1191 to any Wellpath-related entity, a reviewer must establish the entity, the ownership or control relationship, the relevant agreement and the date of the conduct. Historical sponsorship is not current ownership, and a 2026 statute does not govern earlier conduct without a valid temporal analysis. Qualifying for — or falling outside — the new statute does not resolve the older Medical Practice Act question; § 1191(g) says the section does not narrow the existing bar.V22
7. A workable professional-independence standard
Analysis The investigation’s method — offered as an editorial framework, not a legal test any court has adopted — runs in six steps: identify the legal entity; identify the instrument and its time period; classify the financial or administrative mechanism; identify the actual or retained power; identify the protected professional decision it reaches; and test lawful explanations, exceptions and contrary evidence. Actual exercise of a power and retention of a prohibited right are alternative evidentiary paths under Epic. A patient-specific harm event is not required to begin a structural inquiry; financial dependence alone is not enough to finish one.V17
| Hypothesis | Records that would test it | Evidence that would rebut it |
|---|---|---|
| Employment authority displaces professional governance | Employment and supervision agreements; role descriptions; delegations; lawful, nonconfidential evidence of decision rationale | Administrative role only; licensed authority controls clinical-competency decisions; Chapman’s sworn account credited in ECF 87 |
| Defense funding is used as leverage over clinical judgment or testimony | Defense and indemnity instruments; coverage decisions; retention terms; nonprivileged decision records | Coverage-based explanation; independent counsel; no condition tied to clinical conduct or testimony; court-approved withdrawal |
| The physician-owner cannot replace the manager, while the manager can replace the owner | Share-transfer and succession documents; voting agreements; proxies; termination and default provisions; transition terms | Genuine physician governance; no non-licensee owner-replacement power; lawful, workable manager-replacement and continuity terms |
This approach avoids two mistakes: assuming that every management function is the practice of medicine, and assuming that a physician’s name on the corporation guarantees professional independence.
The decisive question is not whether a management organization is powerful. It is whether its enforceable powers intrude on decisions the law reserves to licensed professionals.
The opponent’s best answers
- “The physician denied any connection between the termination and patient care.” Correct, and credited by the court on the present record. It is stated first in this article, not buried.
- “An administrative employee may testify for the corporation.” Correct under Rule 30(b)(6). The question is substance — records, preparation and final authority — not the designee’s payroll.
- “Defense funding stopped because of the bankruptcy, not coercion.” The public record does not refute that, and nothing here infers attorney misconduct from funding or withdrawal.
- “The 2026 statute does not cover this entity or this period.” Possibly so; it has to be checked entity by entity and date by date. The older law applies regardless.
- “This is an end-run around a protective order or a personal dispute.” The series relies only on independently public orders and law, cites no protected discovery, and carries the author’s standing statement of interest rather than a claim of detachment.
Continue: Part 1 · Part 2 · the evidence ledger · Article 049 · Article 058
Source register
- V01Overfield v. County of El Dorado et al. (caption as in the order), No. 2:24-cv-0199 TLN AC (E.D. Cal.), ECF 96 — order granting CFMG’s motion for a protective order
- V03Overfield v. California Forensic Medical Group et al. (caption as in the order), ECF 87 — order on plaintiffs’ motion to compel (ECF 79) and defendants’ protective-order motion (ECF 82)
- V04Overfield v. Wellpath Community Care, LLC et al., ECF 75 — order granting motion to withdraw as counsel for Dr. Ross Chapman (ECF 73)
- V07Federal Rule of Civil Procedure 30(b)(6) — organizational deposition
- V09Overfield, ECF 95 — Joint Discovery Statement re: Discovery Dispute (public redacted filing)
- V16Medical Board of California — Practice Information: Corporate Practice of Medicine (Bus. & Prof. Code §§ 2052, 2400)
- V17Epic Medical Management, LLC v. Paquette (2015) 244 Cal.App.4th 504 (No. B261541)
- V19California Attorney General, amicus curiae brief in support of neither party, Art Center Holdings, Inc. v. WCE CA Art, LLC, No. B338625 (Cal. Ct. App., 2d Dist., Div. 3)
- V20California Attorney General — “Attorney General Bonta Files Amicus Brief in Defense of California’s Ban on Corporate Practice of Medicine”
- V21California Health and Safety Code § 1190 — definitions of “hedge fund” and “private equity group,” with exclusions
- V22California Health and Safety Code § 1191 — private equity and hedge-fund restrictions; (c) void terms; (d) non-compete and non-disparagement; (e) Attorney General enforcement; (g)–(h)
- V23California Rules of Professional Conduct 1.8.6 (compensation from one other than the client) and 5.4(c) (independence from a payer’s direction)